SAB Biotherapeutics, Inc. Warrant (SABSW) is a publicly traded BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector company. As of October 22, 2026, SABSW trades at $0.00 with a market cap of $0 and a P/E ratio of 0.00. SABSW moved -97.67% today. Year to date, SABSW is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SABSW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SABSW, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.00 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 581.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
SABSW analyst coverage data. Average price target: $0.00.